Picture EBD Group Global Partnering Four Events One Price 650x80
Document › Details

MorphoSys AG. (11/5/18). "Press Release: MorphoSys AG Announces Third Quarter 2018 Results". Planegg.

Organisations Organisation MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; Nasdaq: MOR)
  Group MorphoSys (Group)
  Organisation 2 I-Mab (CN)
  Group I-Mab (Group)
Products Product tafasitamab (MOR208 / XmAb5574)
  Product 2 MOR106 (MorphoSys / Galapagos / Novartis)
Index term Index term Leo Pharma–MorphoSys: therapeutic antibodies, 201611– collab strategic alliance to develop ABs in dermatology using Ylanthia technology

Record changed: 2019-06-09


Picture [iito] Plain Stupid Simple 650x80px

More documents for MorphoSys (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Hotspot for Startups 650x80px

» top